JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Hidradenitis Suppurativa Increases Risk of Postoperative Complications After Mohs Surgery: A Retrospective Cohort Study

Published online October 15, 2026

To the Editor, Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by painful nodules, abscesses, and sinus trac...

read more
Q-switched Nd:YAG Laser for Extrafacial Lichen Planus Pigmentosus: A Case Series Highlighting Outcomes and Risks

Published online October 14, 2026

Lichen planus pigmentosus (LPP) is an acquired dermal melanosis that typically affects photo-exposed and flexural surfaces. Q-switched...

read more
Retrospective Review of Dermal Safety Studies of the Organic Sun Filter Bemotrizinol

Published online October 14, 2026

Bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT) is a UVA/UVB sun filter that has been approved for use in the European Union sin...

read more
The Current Landscape of Vitiligo Support Groups: An International Survey of Support Group Leaders

Published online October 9, 2026

Vitiligo can significantly impact the quality of life of affected individuals and their family members. Support groups provide numerou...

read more
Celecoxib, Sirolimus, and Acitretin are Associated With Decreased Non-Melanoma Skin Cancer in the General Population

Published online October 8, 2026

Nonmelanoma skin cancer (NMSC) is the most common malignancy in the United States, and a growing public health concern. 1 While a var...

read more
Cicatricial Ectropion in the Setting of IL-13 Inhibition

Published online September 29, 2026

Inhibition of interleukin (IL)-13, a key mediator of type 2 inflammation, is a highly effective and targeted therapeutic strategy for a...

read more
Fundamentals of Hyperpigmentation Disorders: Causes, Concerns, and Treatment Strategies, Particularly in Skin of Color Patients

Published online September 29, 2026

Pigmentary disorders, including cutaneous hyperpigmentation, are among the most common dermatologic diagnoses in individuals with SOC, ...

read more
Nordic European Countries Atopic Dermatitis (NECAD) I: Importance of Concordance With Skincare for Atopic Dermatitis

Published online September 29, 2026

Atopic dermatitis (AD) is a chronic, relapsing skin disease presenting with inflammation, pruritus, and xerosis. 1,2 A family history ...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

Journal of Drugs in Dermatology JDD featuring The Essential Role of Topical Targeted Therapy in Atopic Dermatitis

The Essential Role of Topical Targeted Therapy in Atopic Dermatitis

| Atopic Dermatitis, Featured Articles, Latest News | No Comments
Beyond Single Target Topicals: Rethinking Atopic Dermatitis Management  Have you read this article from the JDD? Managing atopic dermatitis remains a complex clinical challenge, particularly when standard single-target topical agents…
Journal of Drugs in Dermatology JDD featuring Contact Allergens Associated With Nummular Eczema: A Systematic Review

Contact Allergens Associated With Nummular Eczema: A Systematic Review

| Featured Articles, Latest News | No Comments
Uncovering Hidden Triggers in Nummular Eczema: What the Latest Research Reveals  Have you read this article from the Journal of Drugs in Dermatology (JDD) yet? For dermatology clinicians managing persistent…

Histological Analysis Shows That a Moisturizer Formulated for Dermatoporosis Increases Elastin Content and Improves Skin Elasticity

| Aesthetics, Featured Articles, Latest News | No Comments
Targeted Topical Formulations for Age Related Dermal Fragility and Biomarker Regulation  Have you seen this groundbreaking publication in the JDD? Age-related structural decline, often referred to as dermatoporosis, presents ongoing…

Efficacy and Tolerability of a Topical Pigment-Correcting Serum in Melasma and Post-inflammatory Hyperpigmentation

| Featured Articles, Latest News, Melasma, Video Abstract | No Comments
New Video Abstract Featuring Pearl Grimes, MD, FAAD, Department of Dermatology, University of California, Los Angeles. Hyperpigmentation is characterized by uneven skin tone, commonly due to excess melanin production.1 Hyperpigmentation is…
Journal of Drugs in Dermatology JDD featuring Biopsy Type and Metastatic Recurrence in Melanoma: A Cohort Study

Biopsy Type and Metastatic Recurrence in Melanoma: A Cohort Study

| Featured Articles, Latest News, Oncodermatology, Skin Cancer | No Comments
Surgical Resection Margins in Metastastic Melanoma: New Clinical Insights  This is a must-read article from JDD for clinicians evaluating surgical management strategies in cutaneous oncology. Cutaneous melanoma continues to account…
Journal of Drugs in Dermatology JDD featuring Biologics and Small-Molecule Inhibitors for the Treatment of Nummular Eczema: A Systematic Review

Biologics and Small-Molecule Inhibitors for the Treatment of Nummular Eczema: A Systematic Review

| Featured Articles, Latest News | No Comments
Target Modern Therapies for Nummular Eczema: What the Evidence Shows  Have you read this article from the JDD? Managing nummular eczema in clinical practice remains a persistent hurdle due to…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

See Ya ciAREs: A Review of Mitigation and Management Strategies for Immunotherapy Associated Skin Scares

| Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes TuneIn Spotify Dr. Beth McLellan & Adam Friedman, MD, FAAD Mo’ targeted therapies, mo’skin problems. Some may say, “Bring on the problems” – but why should they have to? Supportive Oncodermatology…
Tune In

Follow Us